Cargando…

A targeted controlled force injection of genetic material in vivo

A general limitation in gene delivery is the cellular uptake in lager animals including humans. Several approaches have been tested including liposomes, micro-needles, in vivo electro-transfer, ballistic delivery, and needle-free delivery. All these techniques have individual limitations. One approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahlén, Gustaf, Frelin, Lars, Holmström, Fredrik, Smetham, Grant, Augustyn, Steve, Sällberg, Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813609/
https://www.ncbi.nlm.nih.gov/pubmed/27069951
http://dx.doi.org/10.1038/mtm.2016.16
_version_ 1782424303051997184
author Ahlén, Gustaf
Frelin, Lars
Holmström, Fredrik
Smetham, Grant
Augustyn, Steve
Sällberg, Matti
author_facet Ahlén, Gustaf
Frelin, Lars
Holmström, Fredrik
Smetham, Grant
Augustyn, Steve
Sällberg, Matti
author_sort Ahlén, Gustaf
collection PubMed
description A general limitation in gene delivery is the cellular uptake in lager animals including humans. Several approaches have been tested including liposomes, micro-needles, in vivo electro-transfer, ballistic delivery, and needle-free delivery. All these techniques have individual limitations. One approach reproducibly delivering genetic material in muscle tissue in nonhuman primates is hydrodynamic injection, a forced injection of a volume equaling the volume of the tissue to be transfected thereby causing an increased local pressure resulting in an improved uptake of genetic material. We transferred the principle of hydrodynamic injection to a device, where a small injection volume can be delivered to a targeted tissue volume, termed in vivo intracellular injection (IVIN). The device is based on needle(s) with apertures along the needle shafts, where multiple needles can fix the tissue volume to be transfected. The apertures direct the injection from a central needle outward or inward to the centroid of a geometric arrangement thereby targeting the tissue to be transfected. With a controlled force, this results in a targeted injection with increased transfection efficiency. We here show that the IVIN technology reproducibly improved plasmid uptake and expression and the immunogenicity. The IVIN technology can be generally applied to a targeted delivery of genetic materials.
format Online
Article
Text
id pubmed-4813609
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48136092016-04-11 A targeted controlled force injection of genetic material in vivo Ahlén, Gustaf Frelin, Lars Holmström, Fredrik Smetham, Grant Augustyn, Steve Sällberg, Matti Mol Ther Methods Clin Dev Article A general limitation in gene delivery is the cellular uptake in lager animals including humans. Several approaches have been tested including liposomes, micro-needles, in vivo electro-transfer, ballistic delivery, and needle-free delivery. All these techniques have individual limitations. One approach reproducibly delivering genetic material in muscle tissue in nonhuman primates is hydrodynamic injection, a forced injection of a volume equaling the volume of the tissue to be transfected thereby causing an increased local pressure resulting in an improved uptake of genetic material. We transferred the principle of hydrodynamic injection to a device, where a small injection volume can be delivered to a targeted tissue volume, termed in vivo intracellular injection (IVIN). The device is based on needle(s) with apertures along the needle shafts, where multiple needles can fix the tissue volume to be transfected. The apertures direct the injection from a central needle outward or inward to the centroid of a geometric arrangement thereby targeting the tissue to be transfected. With a controlled force, this results in a targeted injection with increased transfection efficiency. We here show that the IVIN technology reproducibly improved plasmid uptake and expression and the immunogenicity. The IVIN technology can be generally applied to a targeted delivery of genetic materials. Nature Publishing Group 2016-03-30 /pmc/articles/PMC4813609/ /pubmed/27069951 http://dx.doi.org/10.1038/mtm.2016.16 Text en Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Ahlén, Gustaf
Frelin, Lars
Holmström, Fredrik
Smetham, Grant
Augustyn, Steve
Sällberg, Matti
A targeted controlled force injection of genetic material in vivo
title A targeted controlled force injection of genetic material in vivo
title_full A targeted controlled force injection of genetic material in vivo
title_fullStr A targeted controlled force injection of genetic material in vivo
title_full_unstemmed A targeted controlled force injection of genetic material in vivo
title_short A targeted controlled force injection of genetic material in vivo
title_sort targeted controlled force injection of genetic material in vivo
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813609/
https://www.ncbi.nlm.nih.gov/pubmed/27069951
http://dx.doi.org/10.1038/mtm.2016.16
work_keys_str_mv AT ahlengustaf atargetedcontrolledforceinjectionofgeneticmaterialinvivo
AT frelinlars atargetedcontrolledforceinjectionofgeneticmaterialinvivo
AT holmstromfredrik atargetedcontrolledforceinjectionofgeneticmaterialinvivo
AT smethamgrant atargetedcontrolledforceinjectionofgeneticmaterialinvivo
AT augustynsteve atargetedcontrolledforceinjectionofgeneticmaterialinvivo
AT sallbergmatti atargetedcontrolledforceinjectionofgeneticmaterialinvivo
AT ahlengustaf targetedcontrolledforceinjectionofgeneticmaterialinvivo
AT frelinlars targetedcontrolledforceinjectionofgeneticmaterialinvivo
AT holmstromfredrik targetedcontrolledforceinjectionofgeneticmaterialinvivo
AT smethamgrant targetedcontrolledforceinjectionofgeneticmaterialinvivo
AT augustynsteve targetedcontrolledforceinjectionofgeneticmaterialinvivo
AT sallbergmatti targetedcontrolledforceinjectionofgeneticmaterialinvivo